Risk of osteoporosis among individuals with varicose veins: a multi-institution cohort study.
Cohort study
Menopause
Osteoporosis
Varicose veins
Venous ulcers
Journal
Archives of osteoporosis
ISSN: 1862-3514
Titre abrégé: Arch Osteoporos
Pays: England
ID NLM: 101318988
Informations de publication
Date de publication:
27 Nov 2023
27 Nov 2023
Historique:
received:
24
04
2023
accepted:
12
11
2023
medline:
28
11
2023
pubmed:
27
11
2023
entrez:
26
11
2023
Statut:
epublish
Résumé
The present study showed a significant association between varicose veins and the development of osteoporosis, especially women and patients older than 50 years. Physicians should be alerted to this issue and consider screening for osteoporosis in patients with varicose veins. Osteoporosis might be associated with many skin diseases. However, only a paucity of data addressing the association between varicose veins and subsequent osteoporosis development. The study was aimed to evaluate whether there is an increased risk of osteoporosis among patients with varicose veins. This multi-institution database study was based on Chang Gung Research Database from January 1, 2003, to December 31, 2015. Patients aged 20 years and older with varicose veins were enrolled. Participants in the control group were selected by matching in a 4:1 ratio by sex, age, index date, and comorbidities. The hazard ratios associated with osteoporosis were estimated using Cox regression analysis with competitive risk model. Incidence rate of osteoporosis was assessed in individuals with and without varicose veins. A total of 11,959 patients with varicose veins and 47,633 matched controls were enrolled in the study. The varicose veins group had higher incidence rates than the control group for osteoporosis (46.40 vs 31.92 per 10,000 person-years; adjusted HR 1.481 [95%CI, 1.314-1.669; P < 0.001]). Compared with matched controls, varicose veins patients with or without venous ulcers had 1.711- and 1.443-times increased risk of developing osteoporosis, respectively. Subgroup analysis showed varicose veins were associated with osteoporosis in women and patients older than 50 years. The present study demonstrated individuals with varicose veins had an increased risk of osteoporosis. Physicians should be alerted to this issue and consider screening for osteoporosis in patients with varicose veins, especially among women and patients older than 50 years.
Identifiants
pubmed: 38008860
doi: 10.1007/s11657-023-01351-6
pii: 10.1007/s11657-023-01351-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
141Informations de copyright
© 2023. International Osteoporosis Foundation and Bone Health and Osteoporosis Foundation.
Références
Salari N, Darvishi N, Bartina Y et al (2021) The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg Res 16:609. https://doi.org/10.1186/s13018-021-02821-8
doi: 10.1186/s13018-021-02821-8
pubmed: 34657598
pmcid: 8522202
Chen R, Safiri S, Behzadifar M et al (2022) Health effects of metabolic risks in the United States from 1990 to 2019. Front Public Health 10:751126. https://doi.org/10.3389/fpubh.2022.751126
doi: 10.3389/fpubh.2022.751126
pubmed: 35174121
pmcid: 8841675
Tański W, Kosiorowska J, Szymańska-Chabowska A (2021) Osteoporosis - risk factors, pharmaceutical and non-pharmaceutical treatment. Eur Rev Med Pharmacol Sci 25:3557–3566. https://doi.org/10.26355/eurrev_202105_25838
doi: 10.26355/eurrev_202105_25838
pubmed: 34002830
Rozenberg S, Bruyère O, Bergmann P et al (2020) How to manage osteoporosis before the age of 50. Maturitas 138:14–25. https://doi.org/10.1016/j.maturitas.2020.05.004
doi: 10.1016/j.maturitas.2020.05.004
pubmed: 32631584
Sirufo MM, De Pietro F, Bassino EM, Ginaldi L, De Martinis M (2020) Osteoporosis in skin diseases. Int J Mol Sci 21:4749. https://doi.org/10.3390/ijms21134749
doi: 10.3390/ijms21134749
pubmed: 32635380
pmcid: 7370296
Khovasova NO, Naumov AV, Tkacheva ON, Dudinskaya EN (2021) Characteristics of geriatric and somatic status in patients with osteoporosis. Probl Endokrinol (Mosk) 67:45–54. https://doi.org/10.14341/probl12751
doi: 10.14341/probl12751
pubmed: 34297501
Eberhardt RT, Raffetto JD (2014) Chronic venous insufficiency. Circulation 130:333–346. https://doi.org/10.1161/CIRCULATIONAHA.113.006898
doi: 10.1161/CIRCULATIONAHA.113.006898
pubmed: 25047584
Youn YJ, Lee J (2019) Chronic venous insufficiency and varicose veins of the lower extremities. Korean J Intern Med 34:269–283. https://doi.org/10.3904/kjim.2018.230
doi: 10.3904/kjim.2018.230
pubmed: 30360023
Brand FN, Dannenberg AL, Abbott RD, Kannel WB (1988) The epidemiology of varicose veins: the Framingham Study. Am J Prev Med 4:96–101
doi: 10.1016/S0749-3797(18)31203-0
pubmed: 3395496
Scott TE, LaMorte WW, Gorin DR, Menzoian JO (1995) Risk factors for chronic venous insufficiency: a dual case-control study. J Vasc Surg 22:622–628. https://doi.org/10.1016/s0741-5214(95)70050-1
doi: 10.1016/s0741-5214(95)70050-1
pubmed: 7494366
Sadick NS (1992) Predisposing factors of varicose and telangiectatic leg veins. J Dermatol Surg Oncol 18:883–886. https://doi.org/10.1111/j.1524-4725.1992.tb02921.x
doi: 10.1111/j.1524-4725.1992.tb02921.x
pubmed: 1430543
Matic P, Jolic S, Tanaskovic S et al (2015) Chronic venous disease and comorbidities. Angiology 66:539–544. https://doi.org/10.1177/0003319714541988
doi: 10.1177/0003319714541988
pubmed: 25005764
Chang SL, Huang YL, Lee MC et al (2018) Association of varicose veins with incident venous thromboembolism and peripheral artery disease. JAMA 319:807–817. https://doi.org/10.1001/jama.2018.0246
doi: 10.1001/jama.2018.0246
pubmed: 29486040
pmcid: 5838574
Tsai MS, Lin MH, Lee CP et al (2017) Chang Gung Research Database: a multi-institutional database consisting of original medical records. Biomed J 40:263–269. https://doi.org/10.1016/j.bj.2017.08.002
doi: 10.1016/j.bj.2017.08.002
pubmed: 29179881
pmcid: 6138604
Textor J, Hardt J, Knüppel S (2011) DAGitty: a graphical tool for analyzing causal diagrams. Epidemiology 22:745. https://doi.org/10.1097/EDE.0b013e318225c2be
doi: 10.1097/EDE.0b013e318225c2be
pubmed: 21811114
Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509
doi: 10.1080/01621459.1999.10474144
Lau B, Cole SR, Gange SJ (2009) Competing risk regression models for epidemiologic data. Am J Epidemiol 170:244–256. https://doi.org/10.1093/aje/kwp107
doi: 10.1093/aje/kwp107
pubmed: 19494242
pmcid: 2732996
Mikuła-Pietrasik J, Uruski P, Aniukiewicz K et al (2016) Serum from varicose patients induces senescence-related dysfunction of vascular endothelium generating local and systemic proinflammatory conditions. Oxid Med Cell Longev 2016:2069290. https://doi.org/10.1155/2016/2069290
doi: 10.1155/2016/2069290
pubmed: 27994710
pmcid: 5141312
Arase H, Sugasawa N, Kawatani Y et al (2019) Appropriate surgical treatment of symptomatic primary varicose veins decreases systemic inflammatory biomarkers. Ann Vasc Dis 12:367–371. https://doi.org/10.3400/avd.oa.19-00011
doi: 10.3400/avd.oa.19-00011
pubmed: 31636748
pmcid: 6766771
Filkor K, Németh T, Nagy I et al (2016) The expression of inflammatory cytokines, TAM tyrosine kinase receptors and their ligands is upregulated in venous leg ulcer patients: a novel insight into chronic wound immunity. Int Wound J 13:554–562. https://doi.org/10.1111/iwj.12473
doi: 10.1111/iwj.12473
pubmed: 26192232
Condezo-Hoyos L, Rubio M, Arribas SM et al (2013) A plasma oxidative stress global index in early stages of chronic venous insufficiency. J Vasc Surg 57:205–213. https://doi.org/10.1016/j.jvs.2012.05.085
doi: 10.1016/j.jvs.2012.05.085
pubmed: 23182154
Wi D, Wilson A, Satgé F, Murrell DF (2022) Osteoporosis and psoriasis: a literature review. Clin Exp Dermatol 47:1438–1445. https://doi.org/10.1111/ced.15174
doi: 10.1111/ced.15174
pubmed: 35279869
pmcid: 9543251
Cauley JA, Danielson ME, Boudreau RM et al (2007) Health ABC Study. Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J Bone Miner Res 22:1088–1095. https://doi.org/10.1359/jbmr.070409
doi: 10.1359/jbmr.070409
pubmed: 17419681
Cauley JA, Barbour KE, Harrison SL et al (2016) Inflammatory markers and the risk of hip and vertebral fractures in men: the osteoporotic fractures in men (MrOS). J Bone Miner Res 31:2129–2138. https://doi.org/10.1002/jbmr.2905
doi: 10.1002/jbmr.2905
pubmed: 27371811
Zhao F, Guo L, Wang X, Zhang Y (2021) Correlation of oxidative stress-related biomarkers with postmenopausal osteoporosis: a systematic review and meta-analysis. Arch Osteoporos 16:4. https://doi.org/10.1007/s11657-020-00854-w
doi: 10.1007/s11657-020-00854-w
pubmed: 33400044
Fox JD, Baquerizo-Nole KL, Keegan BR et al (2016) Adalimumab treatment leads to reduction of tissue tumor necrosis factor-alpha correlated with venous leg ulcer improvement: a pilot study. Int Wound J 13:963–966. https://doi.org/10.1111/iwj.12497
doi: 10.1111/iwj.12497
pubmed: 26399369
Haroon NN, Sriganthan J, Al Ghanim N, Inman RD, Cheung AM (2014) Effect of TNF-alpha inhibitor treatment on bone mineral density in patients with ankylosing spondylitis: a systematic review and meta-analysis. Semin Arthritis Rheum 44:155–161. https://doi.org/10.1016/j.semarthrit.2014.05.008
doi: 10.1016/j.semarthrit.2014.05.008
pubmed: 24909809
Gulyás K, Horváth Á, Végh E et al (2020) Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis. Clin Rheumatol 39:167–175. https://doi.org/10.1007/s10067-019-04771-3
doi: 10.1007/s10067-019-04771-3
pubmed: 31522318
Yang NP, Deng CY, Chou YJ et al (2006) Estimated prevalence of osteoporosis from a Nationwide Health Insurance database in Taiwan. Health Policy 75:329–337. https://doi.org/10.1016/j.healthpol.2005.04.009
doi: 10.1016/j.healthpol.2005.04.009
pubmed: 15946761
Vilaca T, Eastell R, Schini M (2022) Osteoporosis in men Lancet Diabetes Endocrinol 10:273–283. https://doi.org/10.1016/S2213-8587(22)00012-2
doi: 10.1016/S2213-8587(22)00012-2
pubmed: 35247315
Anam AK, Insogna K (2021) Update on osteoporosis screening and management. Med Clin North Am 105:1117–1134. https://doi.org/10.1016/j.mcna.2021.05.016
doi: 10.1016/j.mcna.2021.05.016
pubmed: 34688418